HIGHLIGHTS
- who: Camille Fuselier from the laboratoire d'Anatomie Pathologie, France, Université de Lorraine, CRAN, UMR CNRS, Nancy, France University of Wisconsin-Madison have published the Article: Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted Phenacetinum on Melanoma, in the Journal: (JOURNAL)
- what: The authors have evaluated the capacities of Phenacetinum 4CH to decrease the primary melanoma growth by disrupting tumor angiogenesis and evidenced that it may obviously reduce the metastatic progression.
- how: The in_vivo experiments were conducted in conformity with institutional ethical guidelines of the University of Reims Champagne-Ardenne (CEEA-RCA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.